Comparison of changes in serum prostate specific antigen in prostate cancer patients treated either with flutamide or stilboestrol monotherapy

Comparison of changes in serum prostate specific antigen in prostate cancer patients treated either with flutamide or stilboestrol monotherapy

Prostate cancer is a disease of males. Though commoner in the elderly, cases are beginning to be reported in the younger population. It is the commonest cancer diagnosed in males. Risk factors include ageing, genetic/familial factors, racial predilection, increased fat diet, and hormonal imbalance....

Full description

Bibliographic Details
Main Authors: O F Otobo, P D Ekwere, E O Nkposong, K Omoruyi, T Ugbem, E E Eyam
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Nigerian Journal of Medicine
Subjects:
prostate cancer
flutamide
stilboestrol
psa.
Online Access:http://www.njmonline.org/article.asp?issn=1115-2613;year=2020;volume=29;issue=1;spage=94;epage=99;aulast=Otobo;type=0

Internet

http://www.njmonline.org/article.asp?issn=1115-2613;year=2020;volume=29;issue=1;spage=94;epage=99;aulast=Otobo;type=0

Similar Items